Market Research Logo

Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, S

Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)

Executive Summary

A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others.

A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023.

According to Azoth Analytics research report, “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” global antidepressants market is projected to display a robust growth represented by a CAGR of 3.12 % during 2018 – 2023.

The segment of Selective Serotonin Reuptake Inhibitors (SSRIs) drug class witnessed growth at a noteworthy rate over the past few years and in the forecast period on the back of rising awareness related metal disorders, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs market in 2017. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, addition of new drugs, rising disposable incomes, rising number of hospitals and clinics etc.

The report titled “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” has covered and analysed the potential of Global Antidepressants Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressants drug. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Antidepressants Market, By Value (Actual Period: 2013-2017, Forecast Period: 2018-2023)

Antidepressant Drugs Market – Sizing and Growth

Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents

Analysis By Sales Channels - Hospital & Clinics, Retail Pharmacies, Others

Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)

Antidepressant Drugs Market – Sizing and Growth

Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents

Analysis By Sales Channels - Hospital & Clinics, Retail Pharmacies, Others

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia (Actual Period: 2013-2017, Forecast Period: 2018-2023)

Antidepressant Drugs Market – Sizing and Growth

Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents

Other Report Highlights

  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis – Pfizer, GlaxoSmithKline, Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antidepressant Drugs Market Outlook
5. Global Antidepressant Drugs Market: Growth and Forecast
5.1. By Value (2013-2017)
Table 1: Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 2: Global YLDs of Depressive Disorders (2013-2016, %)
Table 3: Global DALYs of Anxiety Disorders (2013-2016 %)
Table 4: DALYs due to Mental and Substance Abuse (2016)
Table 5: World Female Population, 2012-2016 (Million)
Table 6: World Population 65 Years & Above (% of Total), 2012-2016
Table 7: Global Unemployment (2016, 2017E, 2018F, (Millions)
Table 8: Global Health Expenditure Per Capita, By Select Countries, (2016, USD)
Table 9: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
5.2. By Value (2013-2017)
Table 10: Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion)
6. Global Antidepressant Drugs Market: By Drugs Class
6.1. Global Antidepressant Drugs Market-By Drugs Class: Breakdown (%)
6.1.1. Global Antidepressant Drugs Market Size and Share, By Drugs, 2017
Table 11: Global Antidepressant Drugs Market Size, By Drugs, 2017 (%)
6.1.2. Global Antidepressant Drugs Market Size and Share, By Drugs, 2023
Table 12: Global Antidepressant Drugs Market Size, By Drugs Class, 2023F (%)
6.2. Global Selective Serotonin Reuptake Inhibitors Market Overview
6.2.1. By Value (2013-2023)
Table 13: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 14: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table A: List of Major Antidepressant Drugs Include in SSRIs Class
Table 15: SSRIs Antidepressants Usage in Different Disorders (%)
Table B: Licenced Indication of SSRIs
6.3. Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview
6.3.1. By Value (2013-2023)
Table 16: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 17: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table C: List of Major Antidepressant Drugs Include in SNRIs Class
6.4. Global Monoamine Oxidase Inhibitors Market Overview
6.4.1. By Value (2013-2023)
Table 18: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 19: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table D: List of Major Antidepressant Drugs Include in MAOIs Class
6.5. Global Tricyclic Antidepressant Drugs Market Overview
6.5.1. By Value (2013-2023)
Table 20: Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 21: Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table E: List of Major Antidepressant Drugs Include in Tricyclic Class
Table F: List of Major Antidepressant Drugs Include in Tetracyclic Class
6.6. Global Benzodiazepines Antidepressant Drugs Market Overview
6.6.1. By Value (2013-2023)
Table 22: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 23: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table G: List of Major Antidepressant Drugs Include in Benzodiazepines
6.7. Global Antipsychotics Antidepressant Drugs Market Overview
6.7.1. By Value (2013-2023)
Table 24: Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 25: Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
Table H: List of Major Antidepressant Drugs Include in Antipsychotics
6.8. Global Novel Agents Antidepressant Drugs Market Overview
6.8.1. By Value (2013-2023)
Table 26: Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 27: Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
6.9. Global Other Antidepressant Drugs Market Overview
6.9.1. By Value (2013-2023)
Table 28: Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion)
Table 29: Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion)
7. Global Antidepressant Drugs Market: By Sales Channels
7.1. Global Antidepressant Drugs Market-By Sales Channels: Breakdown (%)
7.1.1. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017
Table 30: Global Antidepressant Drugs Market Size, By Sales Channels, 2017 (%)
7.1.2. Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023
Table 31: Global Antidepressant Drugs Market Size, By Sales Channels, 2023 (%)
7.2. Global Antidepressant Drugs Market, By Hospital & Clinics Overview
7.2.1. By Value (2013-2023)
Table 32: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion)
Table 33: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion)
7.3. Global Antidepressant Drugs Market, By Retail Pharmacies Overview
7.3.1. By Value (2013-2023)
Table 34: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2013-2017 (USD Billion)
Table 35: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2018E-2023F (USD Billion)
7.4. Global Antidepressant Drugs Market, By Others Overview
7.4.1. By Value (2013-2023)
Table 36: Global Antidepressant Drugs Market, By Others, By Value, 2013-2017 (USD Billion)
Table 37: Global Antidepressant Drugs Market, By Others, By Value, 2018E-2023F (USD Billion)
8. Global Antidepressant Drugs Market: Pipeline Analysis
Table I: Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication
9. Global Antidepressant Drugs Market: Regional Analysis
9.1. Global Antidepressant Drugs Market, By Region: Breakdown (%)
9.1.1. Global Antidepressant Drugs Market Size, By Region, 2017 (%)
Table 38: Global Antidepressant Drugs Market Size and Share, By Region, 2017
9.1.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%)
Table 39: Global Antidepressant Drugs Market Size and Share, By Region, 2023F
9.2. Global Antidepressant Drugs Market Size, By Region, 2023 (%)
9.2.1. By Value (2013-2017)
Table 40: North America Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
9.2.2. By Value (2018-2023)
Table 41: North America Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
9.3. North America Antidepressant Drugs Market: Segment Analysis
9.3.1. North America Antidepressant Drugs Market: By Drug Class
9.3.1.1. North America Antidepressant Drugs Market Size, By Value, 2013-2023
Table 42: North America Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.3.2. North America Antidepressant Drugs Market: By Sales Channels
9.3.2.1. North America Antidepressant Drugs Market Size, By Value, 2013-2023F
Table 43: North America Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
9.4. North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada)
Table 44: North America Antidepressant Drugs Market, Country Share, 2017 (% of Total)
Table 45: North America Antidepressant Drugs Market, Country Share, 2023 (% of Total)
9.4.1. U.S. Antidepressant Drugs Market, By Value (2013-2023)
Table 46: United States Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 47: United States Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 48: United States YLDs by Anxiety Disorders (2013-2016 %)
Table 49: United States YLDs by Depressive Disorders (2013-2016 %)
Table 50: United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016)
Table J: Facts and Figures Driving High Demand of Antidepressants in United States Market
Table 51: Prevalence of Different Types of Mental Disorders Among United States Adults (2016)
Table 52: Treatment Received Among Adults with Major Depressive Episode (2016)
Table 53: Per Capita Healthcare Expenditure in United States (2012-2016, USD)
Table 54: U.S Health Spending by Type of Service or Product, 2016 (%)
9.4.1.1. U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 55: United States Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.4.2. Canada Antidepressant Drugs Market, By Value (2013-2023)
Table 56: Canada Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 57: Canada Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
9.4.2.1. Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 58: Canada Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.5. Europe Antidepressant Drugs Market: An Analysis
9.5.1. By Value (2013-2017)
Table 59: Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
9.5.2. By Value (2018-2023)
Table 60: Europe Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
9.6. Europe Antidepressant Drugs Market: Segment Analysis
9.6.1. Europe Antidepressant Drugs Market: By Drug Class
9.6.1.1. Europe Antidepressant Drugs Market Size, By Value, 2013-2023
Table 61: Europe Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.6.2. Europe Antidepressant Drugs Market: By Sales Channels
9.6.2.1. Europe Antidepressant Drugs Market Size, By Value, 2013-2023F
Table 62: Europe Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
9.7. Europe Antidepressant Drugs Market: Country Analysis (U.K., Germany & Rest of Europe)
Table 63: Europe Antidepressant Drugs Market, Country Share, 2017 (% of Total)
Table 64: Europe Antidepressant Drugs Market, Country Share, 2023 (% of Total)
9.7.1. United Kingdom Antidepressant Drugs Market, By Value (2013-2023)
Table 65: United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 66: United Kingdom Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 67: United Kingdom YLDs by Depressive Disorders (2013-2016 %)
Table 68: Antidepressant Dispensed in England (2005, 2015, 2016, Million Units)
Table 69: United Kingdom YLDs by Anxiety Disorders (2013-2016 %)
Table 70: Per Capita Healthcare Expenditure in United Kingdom (2012-2016, USD)
Table 71: U.K. Population 65 Years & Above (% of Total), 2012-2016
9.7.1.1. United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 72: United Kingdom Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.7.2. Germany Antidepressant Drugs Market, By Value (2013-2023)
Table 73: Germany Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 74: Germany Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 75: Private Healthcare Spending in Germany, US Dollar/capita (2012-2016)
Table 76: Germany Per Capita Healthcare Expenditure (2012-2016, USD)
Table 77: Germany YLDs & DALYs by Depressive Disorders (2013-2016 %)
9.7.2.1. Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 78: Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.7.3. Rest of Europe Antidepressant Drugs Market, By Value (2013-2023)
Table 79: Rest of Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 80: Rest of Europe Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
9.8. Asia Pacific Antidepressant Drugs Market: An Analysis
9.8.1. By Value (2013-2017)
Table 81: Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
9.8.2. By Value (2018-2023)
Table 82: Asia Pacific Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
9.9. Asia Pacific Antidepressant Drugs Market: Segment Analysis
9.9.1. Asia Pacific Antidepressant Drugs Market: By Drug Class
9.9.1.1. Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023
Table 83: Asia Pacific Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.9.2. Asia Pacific Antidepressant Drugs Market: By Sales Channels
9.9.2.1. Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F
Table 84: Asia Pacific Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
9.10. Asia Pacific Antidepressant Drugs Market: Country Analysis (Germany, U.K., & Rest of Europe)
Table 85: Asia Pacific Antidepressant Drugs Market, Country Share, 2017 (% of Total)
Table 86: Asia Pacific Antidepressant Drugs Market, Country Share, 2023 (% of Total)
9.10.1. India Antidepressant Drugs Market, By Value (2013-2023)
Table 87: India Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 88: India Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 89: Prevalence of Depressive Disorders in India By Age and Sex- (2015-2016)
Table 90: India Healthcare Expenditure (2012-2016, USD Billion)
9.10.1.1. India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 91: India Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.10.2. China Antidepressant Drugs Market, By Value (2013-2023)
Table 92: China Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 93: China Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 94: China YLDs by Anxiety Disorders (2013-2016 %)
Table 95: China YLDs & DALYs by Depressive Disorders (2013-2016 %)
Table 96: China Healthcare Expenditure (2012-2016, USD Billion)
Table 97: China Population 65 Years & Above (% of Total), 2012-2016
9.10.2.1. China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 98: China Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.10.3. Japan Antidepressant Drugs Market, By Value (2013-2023)
Table 99: Japan Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 100: Japan Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
Table 101: Japan Per Capita Health Expenditure (2012-2016, USD)
Table 102: Japan YLDs by Depressive Disorders (2013-2016 %)
Table 103: Japan Population 65 Years & Above (% of Total), 2012-2016
9.10.3.1. Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 104: Japan Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.10.4. Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023)
Table 105: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 106: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
9.11. Rest of World Pacific Antidepressant Drugs Market: An Analysis
9.11.1. By Value (2013-2017)
Table 107: Rest of World Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
9.11.2. By Value (2018-2023)
Table 108: Rest of World Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion)
9.12. Rest of World Antidepressant Drugs Market: Segment Analysis
9.12.1. Rest of World Antidepressant Drugs Market: By Drug Class
9.12.1.1. Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023
Table 109: Rest of World Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.12.2. Rest of World Antidepressant Drugs Market: By Sales Channels
9.12.2.1. Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F
Table 110: Rest of World Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion)
9.13. Rest of World Antidepressant Drugs Market: Country Analysis (Brazil, Saudi Arabia & Others)
Table 111: Rest of World Antidepressant Drugs Market, Country Share, 2017 (% of Total)
Table 112: Rest of World Antidepressant Drugs Market, Country Share, 2023 (% of Total)
9.13.1. Brazil Antidepressant Drugs Market, By Value (2013-2023)
Table 113: Brazil Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 114: Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
9.13.1.1. Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 115: Brazil Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.13.2. Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023)
Table 116: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 117: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
9.13.2.1. Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023)
Table 118: Saudi Arabia Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
9.13.3. Others Antidepressant Drugs Market, By Value (2013-2023)
Table 119: Others Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Table 120: Others Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion)
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends
12. Policy and Regulatory Landscape
13. Porter’s Five Forces Analysis – Antidepressant Drugs Market
14. SWOT Analysis – Antidepressant Drugs Market
15. Company Profiles
15.1. Allergan
15.2. Eli Lilly
15.3. Pfizer
Table 121: Pfizer Segmental Breakup, 2016 (%)
Table 122: Pfizer Sales, By Region, 2016 (%)
15.4. Takeda
Table 123: Takeda Segmental Break Up
Table 124: Takeda Geographical Break Up
15.5. GlaxoSmithKline
15.6. Novartis
Table 125: Novartis Sales, By Segment 2015 (%)
Table 126: Novartis Sales, By Region, 2015 (%)
Table 127: Novartis Pharmaceuticals Sales, By Franchise, 2015 (%)
15.7. Forest Laboratories

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report